DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,409,325 | -38.9% | 17,772 | -40.9% | 0.07% | -39.5% |
| Q2 2023 | $7,211,460 | -4.6% | 30,048 | +0.2% | 0.11% | -9.5% |
| Q1 2023 | $7,558,993 | -29.5% | 29,991 | -25.8% | 0.13% | -35.1% |
| Q4 2022 | $10,723,173 | +257.2% | 40,401 | +247.6% | 0.19% | +145.6% |
| Q3 2022 | $3,002,000 | -0.2% | 11,623 | -2.0% | 0.08% | +16.2% |
| Q2 2022 | $3,008,000 | -12.8% | 11,864 | +0.8% | 0.07% | -1.4% |
| Q1 2022 | $3,451,000 | -24.2% | 11,766 | -15.0% | 0.07% | -25.0% |
| Q4 2021 | $4,552,000 | -4.6% | 13,835 | -11.7% | 0.09% | -1.1% |
| Q3 2021 | $4,769,000 | +32.9% | 15,664 | +17.2% | 0.09% | +9.4% |
| Q2 2021 | $3,588,000 | +26.7% | 13,369 | +6.3% | 0.08% | +9.0% |
| Q1 2021 | $2,832,000 | +49.5% | 12,580 | +47.5% | 0.08% | +27.9% |
| Q4 2020 | $1,894,000 | +0.9% | 8,526 | -2.2% | 0.06% | -14.1% |
| Q3 2020 | $1,877,000 | +90.9% | 8,717 | +56.8% | 0.07% | +69.0% |
| Q2 2020 | $983,000 | +45.8% | 5,558 | +14.2% | 0.04% | +16.7% |
| Q1 2020 | $674,000 | -7.2% | 4,867 | +3.0% | 0.04% | +16.1% |
| Q4 2019 | $726,000 | +6.6% | 4,724 | +0.0% | 0.03% | +3.3% |
| Q3 2019 | $681,000 | -0.9% | 4,722 | -2.4% | 0.03% | -3.2% |
| Q2 2019 | $687,000 | +75.3% | 4,837 | +62.4% | 0.03% | +55.0% |
| Q1 2019 | $392,000 | +24.1% | 2,978 | -3.0% | 0.02% | +11.1% |
| Q4 2018 | $316,000 | +1.9% | 3,071 | +6.8% | 0.02% | +20.0% |
| Q3 2018 | $310,000 | -12.2% | 2,875 | -18.0% | 0.02% | -44.4% |
| Q2 2016 | $353,000 | -16.4% | 3,505 | -21.3% | 0.03% | -22.9% |
| Q1 2016 | $422,000 | +79.6% | 4,455 | +61.7% | 0.04% | +75.0% |
| Q2 2015 | $235,000 | +1.3% | 2,755 | -0.1% | 0.02% | -4.8% |
| Q1 2015 | $232,000 | -5.7% | 2,757 | -4.3% | 0.02% | -12.5% |
| Q4 2014 | $246,000 | +13.4% | 2,881 | -0.1% | 0.02% | +41.2% |
| Q3 2014 | $217,000 | -15.6% | 2,884 | -13.9% | 0.02% | -55.3% |
| Q4 2013 | $257,000 | – | 3,350 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |